铭利达 20250709 摘要 铭利达早期依赖光伏领域，特别是 Solaredge 和 Enphase 两大客户， 2022 年业绩高速增长，但 2023 年底受逆变器去库存影响，业绩和股 价承压，与主要客户股价呈现强相关性。 2024 年，铭利达面临国内市场竞争加剧、海外光储逆变器去库存、海 外汽车客户放量不足等多重挑战，导致营收大幅下滑，毛利率下降，并 计提 1.8 亿元资产减值损失，整体亏损达 4.7 亿元。 公司积极拓展汽车领域客户，但国内市场竞争激烈导致汽车业务毛利率 大幅下滑至 12.1%，同比下降 7.8 个百分点，对整体盈利能力造成负面 影响。 铭利达为应对产能受限，在国内和海外大幅扩产，但海外基地建设周期 长，前期成本费用高，导致 2024 年仍处于亏损状态，资本开支压制了 2022-2024 年的盈利水平。 公司通过关停并转国内生产基地，计提资产减值损失，并重点拓展新能 源汽车领域的国内外客户，2024 年新能源汽车营收占比已达 56%，预 计 2025 年仍将是最高营收占比行业。 Q&A 铭利达公司在 2023 年面临哪些主要挑战？ 2023 年铭利达公司面临三重压力。首先，海外光储市场 ...

Core Viewpoint - Hongte Technology has announced a plan to raise up to 650 million RMB through a rights issue, which is seen as unfavorable for minority shareholders given the company's weak profitability and high fundraising amount compared to its historical net profits [1][3][8]. Group 1: Company Financials and Fundraising - The company plans to issue shares at a ratio of 4 shares for every 10 held, aiming to raise a total of 650 million RMB, which is 24 times its net profit of 27 million RMB over the past five years [3][8]. - The funds raised will be allocated to projects including the construction of a production base in Thailand, technical upgrades at its Zhaoqing base, and the establishment of a headquarters R&D center [3][4]. - Hongte Technology's net profits over the last five years have been 0.21 million RMB, -0.48 million RMB, 0.11 million RMB, 0.15 million RMB, and 0.28 million RMB, totaling only 27 million RMB [8]. Group 2: Impact on Minority Shareholders - The rights issue will dilute the net asset value and earnings per share for minority shareholders, creating a dilemma where they must either invest more cash or face dilution of their ownership [2][4][5]. - If minority shareholders choose not to participate in the rights issue, their ownership percentage will decrease, impacting their influence and potential earnings from the company [5][6]. - The issuance of up to 154,912,320 new shares represents 40% of the total share capital before the issue, significantly affecting the financial metrics for existing shareholders [4][8]. Group 3: Control and Financing Concerns - The controlling shareholder, Guangdong Baibanghe Industrial Investment Co., has pledged 50% of its shares for financing, raising questions about the source of funds for its participation in the rights issue [10][12]. - The potential for the controlling shareholder to use funds from share pledges to subscribe to new shares could exacerbate financial risks and lead to a cycle of leverage that may destabilize the company's ownership structure [12]. - The company's management has stated that the rights issue aligns with its long-term financing needs and strategic goals, despite the apparent risks to minority shareholders [6][7].

2025 年 06 月 27 日 业绩短期承压，多轮驱动中长期成长 —美利信（301307.SZ）公司动态研究报告 买入(首次) 投资要点 ▌下游多点开花，铝合金精密压铸件需求不减 铝合金精密压铸件制造行业产业链跨度长、覆盖面广，下游 行业包括通信、储能、汽车、散热等众多应用领域。其中随 着 5G 网络覆盖扩大，预计到 2030 年 5G 签约用户数量将达到 63 亿，移动通信行业市场广阔；汽车轻量化已成趋势，铝合 金成为油车、新能源车的首选材料，相关轻量铸件的需求有 望迎来增长。综合来看各行业景气度不减，将持续释放对铝 合金精密压铸件需求。 ▌汽车+通信双向发力，多轮驱动中长期成长 公司深耕精密压铸领域多年，新能源汽车领域能够为客户提 供电驱动系统、电控系统、动力电池系统和车身结构件铝合 金精密压铸件，业务深度合作新势力车企如蔚来、小鹏、赛 力斯等；通信领域，除了 5G 基站大型结构件设计制造，不断 研发新一代散热材料，绑定爱立信等头部客户。公司持续深 耕新能源汽车和通信两大主业，并拓展半导体、储能等新行 业，未来有望带来新增长。 ▌业绩短期承压，静待全球化提速 2024 年公司实现收入 36.59 亿元（ ...

Group 1: Company Announcements - Jingce Electronics' subsidiary signed sales contracts for semiconductor measurement equipment totaling 113 million yuan [1] - Zhifei Biological plans to issue company bonds not exceeding 6 billion yuan for technology innovation and working capital [1] - Rijiu Optoelectronics' subsidiary plans to invest 822 million yuan in a functional film project with an annual production capacity of 6 million square meters [1] - Huiyun Titanium Industry's subsidiary intends to acquire a 53.125% stake in Chenshang Mining for 30.6 million yuan and increase capital by 32.4 million yuan [2] - Hongte Technology plans to raise up to 650 million yuan through a rights issue for various projects and working capital [2] - Jincheng Pharmaceutical's subsidiary received FDA approval for the active pharmaceutical ingredient Posaconazole [4] - Kairun Co. plans to reduce its shareholding by up to 2% due to personal funding needs [5] - Rundou Co. passed an FDA inspection for nine active pharmaceutical ingredients [6] - Sanyou Lianzhong's shareholders plan to reduce their holdings by up to 3% due to funding needs [7] - *ST Yazhen's stock was suspended for trading due to a significant price increase of 29.43% [9] - Online and Offline plans to change control with a share transfer agreement, leading to a new controlling shareholder [10] - Dazhong Mining intends to purchase office space from an affiliate for 50.17 million yuan [11] - Suzhou Bank's major shareholder increased its stake by 856 million yuan [12] - *ST Fanli's subsidiary plans to acquire a 60% stake in Guangzhou Fengteng for up to 28.8 million yuan [14] - Hengmingda's major shareholders plan to reduce their holdings by up to 3.15% [16] - Guomai Technology's shareholder plans to reduce its stake by up to 1% due to funding needs [17] - ST Bailin's stock will change its name to Guizhou Bailin and remove risk warnings [17] - *ST Xianfeng's stock will change its name to Xianfeng Holdings and remove risk warnings [18] - Maiwei Bio signed an exclusive licensing agreement with CALICO for a monoclonal antibody, receiving an upfront payment of 25 million USD [19] - Maiwei Bio signed a technology licensing agreement with Qilu Pharmaceutical for a new drug project, with a total payment of up to 500 million yuan [21] - Maiwei Bio plans to repurchase shares worth between 25 million and 50 million yuan [22] - Mengwang Technology plans to acquire 100% of Bicheng Digital for 1.28 billion yuan to expand its e-commerce services [22] Group 2: Industry Overview - Jingce Electronics operates in the mechanical equipment sector, focusing on measurement systems for displays, semiconductors, and new energy [1] - Zhifei Biological is in the pharmaceutical sector, specializing in vaccine and biological product development [1] - Rijiu Optoelectronics is part of the electronics industry, focusing on touch display materials and functional films [1][2] - Huiyun Titanium Industry operates in the basic chemicals sector, focusing on titanium dioxide products [2] - Hongte Technology is in the automotive industry, specializing in aluminum alloy precision die-casting for automotive components [2][3] - Jincheng Pharmaceutical is in the pharmaceutical sector, focusing on chemical pharmaceuticals and active ingredients [4] - Rundou Co. operates in the pharmaceutical sector, focusing on chemical drug formulations and raw materials [6] - Sanyou Lianzhong is in the electrical equipment sector, specializing in relays and transformers [7] - *ST Yazhen operates in the light industry, focusing on high-end furniture products [9] - Online and Offline is in the communication sector, focusing on communication services and applications [10] - Dazhong Mining operates in the steel industry, focusing on iron ore mining and processing [11] - Suzhou Bank is a city commercial bank, providing various banking services [12] - *ST Fanli operates in the media sector, focusing on online advertising and marketing services [14] - Hengmingda is in the electronics sector, focusing on precision components for consumer electronics [16] - Guomai Technology operates in the education sector, focusing on IoT technology services [17] - ST Bailin is in the energy sector, providing engineering consulting and smart factory solutions [17] - *ST Xianfeng operates in the animal health sector, focusing on vaccines and animal nutrition [18] - Maiwei Bio is in the pharmaceutical sector, focusing on biopharmaceuticals [19][21][22] - Mengwang Technology operates in the communication sector, focusing on cloud platform services [22]

长江商报记者注意到，此次所回购的股份将用于员工持股计划或股权激励，有利于完善公司法人治理结 构，增强公司的核心竞争力。 据了解，爱柯迪成立于2003年，是一家专业从事汽车铝合金精密压铸件研发、生产及销售的企业。值得 一提的是，自2017年A股上市以来，爱柯迪积极回馈投资者。公司累计分红金额高达17.74亿元，分红比 例为38.5%。 业绩方面，2025年一季度，公司实现营收16.66亿元，同比增长1.41%；净利润2.57亿元，同比增长 10.94%；扣非净利润2.36亿元，同比增长6.64%；总资产149.2亿元，相比上年度末增加4.5%。 全球中小件压铸"隐形冠军"爱柯迪（600933）(600933.SH)向市场释放信心。 6月18日，爱柯迪公告称，公司计划以集中竞价交易方式回购部分A股股票，回购金额不低于1亿元且不 超过2亿元，回购价格不超过24.17元/股。 数据显示，上市之后，爱柯迪的盈利能力曾出现波动。2022年开始，公司业绩止跌回升并保持高速增长 态势。 拟最高2亿回购用于股权激励 6月18日晚，爱柯迪公告，公司拟使用自有资金或自筹资金通过上海证券交易所交易系统以集中竞价交 易方式回购公司已发 ...

文/新浪财经上海站陈秀颖 6月18日，爱柯迪发布人事任命公告，引发市场关注。董事俞国华之子俞程允出任副总经理，掌舵多年财务的奚海军因健康隐退转任顾问，齐桂玉接棒财务 总监。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 俞程允的接任引发市场瞩目，这不仅关乎家族企业的薪火相传，更体现了人才梯队建设的未雨绸缪。他持股任职的背景，向市场传递出责任与利益深度绑定 的信号。 高管变动：新老交替间的缜密棋局 据董事会公告，俞程允的任命即刻生效，任期与公司第四届董事会一致。这位新任副总不仅是核心董事俞国华之子，毕业于纽约大学技术管理专业，硕士学 历，上海交通大学EMBA在读。2021年9月至2024年12月，历任公司二号工厂运营副总监助理、项目经理、二号工厂项目管理部经理、二号工厂运营副总 监、业务二单元销售总监、美国市场开发部总监；2022年6月至今，任H客户项目总监；2024年12月至今，任公司总经理助理。 俞程允持有公司2.7万股股份，其背景引发市场侧关注。尽管存在亲属关联，但公司明确强调其"完全符合任职资格"，回应了可能的质疑声浪。 据2024年年报显示，副总经理兼董事会秘书董丽萍薪酬1 ...

Core Viewpoint - Ningbo Longyuan Co., Ltd. has been accepted for IPO on the Beijing Stock Exchange, aiming to raise 610 million yuan for projects related to new energy systems and lightweight automotive components [2]. Company Overview - Ningbo Longyuan was established in 2006 with a registered capital of 51 million yuan, specializing in the R&D, production, and sales of aluminum alloy precision die-casting parts, recognized as a national "little giant" enterprise [2]. - The actual controllers of the company, Lin Guodong and Tang Meiyun, directly and indirectly control 98.5% of the shares, with Lin holding 55.9% and Tang holding 14.3954% directly, along with additional indirect control through other entities [2]. Management Team - The current management team includes: - Zhang Yutian as General Manager (2023-2026) - Tang Meiyun as Deputy General Manager (2023-2026) - Chen Hao, Shen Lunlian, and Xu Zhihui as Deputy General Managers and Financial Director respectively [3]. - Lin Guodong transitioned to Chairman in 2023, while Tang Meiyun moved to the role of Deputy General Manager [3][6]. Shareholding Structure - The shareholding structure indicates that Lin Guodong and Tang Meiyun have significant control over the company, with Lin Guodong directly holding 55.9% and additional indirect holdings through Jialong Holdings [2][5].

证 券 研 究 报 告 公司深度报告 铝合金压铸领军企业，积极开拓第二增长曲线 嵘泰股份（ ） 605133.SH 投资评级： （ ） 报告日期：2025年06月18日 买入 维持 ◼ 分析师：林子健 ◼ SAC编号：S1050523090001 投 资 要 点 转向器壳体全球领军企业，优质客户赋予成长动能 嵘泰股份成立于2000年，主要产品为汽车转向、传动、制动等铝合金精密压铸件。2011年公司与博世合作电动转向壳 体，完成大众EPS首个国产化项目，逐渐与博世、采埃孚、蒂森克努伯等全球知名汽车Tier1建立了持续稳定的合作关系， 公司转向器壳体零部件市占率从2017年的12.43%逐年攀升至2021年的21.46%，处于市场领先地位。公司依托电动转向 机壳体产品优势+新能源三电等新产品布局，新获/新增开发博世、采埃孚、蒂森克虏伯、蔚来等新项目。除通过原先 Tier1客户进行配套外，公司新能源三电系统产品直接供应国内外头部新能源车企，实现从Tier2到Tier1的突破，相关产 品已陆续量产 ，带动公司营收快速增长。 墨西哥二期工厂产能逐步释放，对美贸易风险整体可控 墨西哥工厂供应特斯拉 Cybertruck零 ...

证券研究报告 | 2025年06月10日 爱柯迪（600933.SH） 卓尔博项目获上交所受理，主业增长稳健 | 公司研究·公司快评  | |  | 汽车·汽车零部件 | 投资评级：优于大市（维持）  | | --- | --- | --- | --- | --- | | 证券分析师： | 唐旭霞 | 0755-81981814 | tangxx@guosen.com.cn | 执证编码：S0980519080002 | | 证券分析师： | 贾济恺 | 021-61761026 | jiajikai@guosen.com.cn | 执证编码：S0980524090004 | 事项： 公司公告：2025 年 5 月 26 日，公司收到上海证券交易所出具的《关于受理爱柯迪股份有限公司发行股份 购买资产并募集配套资金申请的通知》（上证上审（并购重组）〔2025〕33 号），上交所依据相关规定 对公司报送的发行股份购买资产并募集配套资金的申请文件进行了核对，认为该项申请文件齐备，符合法 定形式，决定予以受理并依法进行审核。公司同步披露了《爱柯迪股份有限公司发行股份及支付现金购买 资产并募集配套资金报告书（草案 ...

IPO Review and Registration Progress - Three IPO applications were accepted last week, including Senhe High-Tech aiming for the Beijing Stock Exchange to raise 490 million yuan, Yisiwei targeting the Sci-Tech Innovation Board with a planned raise of 1.214 billion yuan, and Zhixin Co. applying for an IPO on the Shanghai Main Board with a target of 1.329 billion yuan [2][3] - Senhe High-Tech specializes in the R&D, production, and sales of environmentally friendly precious metal mining agents, with sales revenue from these agents accounting for over 95% of its main business income during the reporting period [2] - Yisiwei focuses on automotive manufacturing machine vision equipment, holding the largest market shares in China’s automotive manufacturing and complete vehicle manufacturing machine vision markets at 13.7% and 22.5% respectively [3] - Zhixin Co. develops and produces automotive welding parts and related molds, with over 70% of its revenue coming from its top five customers [3] Recent IPO Approvals and Upcoming Listings - Huaxin Precision passed its IPO review on June 6, focusing on precision stamping products, with a projected revenue of 1.421 billion yuan in 2024, a 19.49% increase year-on-year [4] - Three companies are set to undergo IPO reviews this week, including Sanxie Electric, which reported steady revenue growth from 287 million yuan in 2022 to 420 million yuan in 2024 [4][5] - United Power, a subsidiary of Huichuan Technology, achieved a revenue of 16.178 billion yuan in 2024, a 72.74% increase, with over 85% of its revenue derived from electric drive systems [5] - Daoshengtianhe, a wind power industry chain company, reported a revenue of 3.238 billion yuan in 2024, a slight increase of 1.13% [6] New Stock Listings and Subscription Dynamics - Two new stocks were listed last week, Zhongce Rubber and Youyou Green Energy, with the latter seeing a significant first-day increase of 68.64% [9][10] - This week, Jiao Da Tie Fa is scheduled to be listed on June 10, with a projected revenue of 335 million yuan in 2024 [10] - Two new stocks are set for subscription this week, including Huazhi Jie and New Henghui, with planned fundraising of approximately 486 million yuan and 519 million yuan respectively [11] Policy and Regulatory Developments - The China Securities Regulatory Commission (CSRC) announced plans to support high-quality unprofitable technology companies in going public, emphasizing the importance of information disclosure and market intermediary verification [12] - The China Listed Companies Association released guidelines for audit committees to enhance compliance and governance among listed companies [13]